About Synfine Drugs
Synfine Drugs is a Healthcare company based in Hyderabad (India) founded in 2020. It manufactures and exports pharmaceutical intermediates and active ingredients globally. It operates on a B2B model. The company has 21 employees. Its Indian entity Synfine Drugs Private Limited reported revenue of ₹7.97 Cr. Synfine Drugs offers products and services including Pharmaceutical Intermediates and Active Pharmaceutical Ingredients. Its focus areas include Pharmaceuticals, API Manufacturing, Active Ingredients and Chemical Intermediates. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Synfine Drugs Private Limited, based in Hyderabad, India, produces and exports Active Pharmaceutical Ingredients and Intermediates. Established in 2020, the company focuses on innovation and quality, adhering to ISO 9001:2015 and GMP standards. It serves global pharmaceutical manufacturers by providing compliant and affordable products through responsible manufacturing processes.
- Headquarters Hyderabad, India
- Employees 21
- SectorsHealthcare
- Email••••••••
- Website synfinedrugs.com
- Legal Name Synfine Drugs Private Limited
- Date of Incorporation 20 Mar, 2017
- Jurisdiction Sangareddy, Telangana, India
- Annual Revenue₹7.97 Cr
FY 2023 · +12% YoY
- Net Profit₹1.10 Cr
FY 2023 · 14% margin
- EBITDA₹3.15 Cr
FY 2023 · 40% margin
- Employee Count21
Associated legal entities of Synfine Drugs
Synfine Drugs operates through Synfine Drugs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Synfine Drugs Private Limited CIN U24304TG2017PTC116006 | Active | 20 Mar 2017 | Sangareddy, Telangana | ₹8.0 Cr | 21 | 2 | View details |
Products & Services of Synfine Drugs
Synfine Drugs offers a comprehensive portfolio of products and services, including Pharmaceutical Intermediates and Active Pharmaceutical Ingredients.
Intermediates for use in pharmaceutical manufacturing processes
Key components for drug formulations and treatments
Board of directors of Synfine Drugs Private Limited (Synfine Drugs)
Synfine Drugs Private Limited is the primary company behind Synfine Drugs. The board of Synfine Drugs Private Limited currently have 2 directors; the longest-serving is Saida Reddy Battu, appointed in 2017.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Saida Reddy Battu DIN 00277759 | Managing Director | 20 Mar 2017 | 9 yrs 7 mo | Synfine Drugs Private Limited |
| Chandra Kala Battu DIN 02440296 | Director | 20 Mar 2017 | 9 yrs 7 mo | Synfine Drugs Private Limited |
Financials of Synfine Drugs
Figures of Synfine Drugs Private Limited, the primary company behind Synfine Drugs, for FY 2023. Revenue was ₹7.97 Cr (+12% year on year). Net profit was ₹1.10 Cr (14% margin). EBITDA was ₹3.15 Cr (40% margin).
- ₹7.97 CrRevenue · FY 2023 · +12% YoY
- ₹1.10 CrNet profit · 14% margin
- ₹3.15 CrEBITDA · 40% margin
- ₹4.87 CrPaid-up capital
- 21Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Synfine Drugs Private Limited are on its company page.
Detailed financial statements for Synfine Drugs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Synfine Drugs
Synfine Drugs has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Synfine Drugs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Synfine Drugs
Synfine Drugs was founded in 2020.
Synfine Drugs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Synfine Drugs has 21 employees.
The primary company behind Synfine Drugs, Synfine Drugs Private Limited, reported revenue of ₹7.97 Cr for FY 2023, up 12% year on year.
Synfine Drugs Private Limited, based in Hyderabad, India, produces and exports Active Pharmaceutical Ingredients and Intermediates. Established in 2020, the company focuses on innovation and quality, adhering to ISO 9001:2015 and GMP standards. It serves global pharmaceutical manufacturers by providing compliant and affordable products through responsible manufacturing processes.
Synfine Drugs's top competitors include Laurus Labs, Symbiotec and SeQuent.
Synfine Drugs offers Pharmaceutical Intermediates and Active Pharmaceutical Ingredients.
Synfine Drugs operates through Synfine Drugs Private Limited.
The legal entities of Synfine Drugs currently have 2 directors, including Saida Reddy Battu, Chandra Kala Battu.